Alnylam to Webcast Conference Call Discussing Second Quarter 2026 Financial Results
AI Briefing
- • Alnylam to report Q2 2026 financial results on July 30, 2026, before US financial markets open.
- • Conference call to discuss Q2 results and future expectations on July 30, 2026 at 8:30 am ET.
- • Webcast available only in paid plans.
Source Summary
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the second quarter ending June 30, 2026 on Thursday, July 30, 2026, before the U.S. financial markets open. Management will provide an update on the Company and discuss second quarter 2026 results as well as expectations for the future via conference call on Thursday, July 30, 2026 at 8:30 am ET. A live audio webcast of
Advertisement